APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Fungal Infection Diagnosis

Invasive candidiasis is an infection caused by a yeast (a type of fungus) called Candida. Unlike Candida infections in the mouth and throat (also called “thrush”) or vaginal “yeast infections,” invasive candidiasis is a serious infection that can affect the blood, heart, brain, eyes, bones, and other parts of the body. Candidemia, a bloodstream infection with Candida, is a common infection in hospitalized patients

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Invasive candidiasis is an infection caused by a yeast (a type of fungus) called Candida. Unlike Candida infections in the mouth and throat (also called “thrush”) or vaginal “yeast infections,” invasive candidiasis is a serious infection that can affect the blood, heart, brain, eyes, bones, and other parts of the body. Candidemia, a bloodstream infection with Candida, is a common infection in hospitalized patients

At present, most hospitals are carrying out non-invasive laboratory diagnosis techniques such as G test and GM test.

Selected research

Market Outlook & Growth Opportunities

Global Fungal Infection Diagnosis Market Outlook and Growth Opportunities 2026

Report ID 173894230431 December 2025195 pages

Choose your research edition.

Industry ResearchFungal Infection Diagnosis Industry Research Report 2026113 pages · $2,950 USDIndustry Growth & TrendsGlobal Fungal Infection Diagnosis Industry Growth and Trends Forecast to 203286 pages · $3,450 USDMarket StructureGlobal Fungal Infection Diagnosis Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Fungal Infection Diagnosis Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Fungal Infection Diagnosis Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

Invasive candidiasis is an infection caused by a yeast (a type of fungus) called Candida. Unlike Candida infections in the mouth and throat (also called “thrush”) or vaginal “yeast infections,” invasive candidiasis is a serious infection that can affect the blood, heart, brain, eyes, bones, and other parts of the body. Candidemia, a bloodstream infection with Candida, is a common infection in hospitalized patients

At present, most hospitals are carrying out non-invasive laboratory diagnosis techniques such as G test and GM test.

ASSOCIATES OF CAPE COD, BioRad, IMMY and other leading products occupy a leading position in the international market, with a total market share OF about 80% in the global market. Among them, Jinshanchuan, Danna Biological and Zhanjiang A & C Biological are domestic production enterprises in China, accounting for more than 90% in 2019.

Read the full market overview

Among the two types of products, the galactomannan experiment accounts for the largest proportion, and in 2019, it accounts for about 60% of the market. The downstream application markets for the diagnosis of fungal infections are mainly hospitals, laboratories and others. Among them, hospitals accounted for the largest proportion.

This report provides an overview of the global Fungal Infection Diagnosis market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Fungal Infection Diagnosis and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Fungal Infection Diagnosis revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Fungal Infection Diagnosis market.

Fungal Infection Diagnosis Segment by Company

ASSOCIATES OF CAPE COD

BioRad

IMMY

Beijing Jinshanchuan

Danna Biological

Zhanjiang A & C Biological Ltd.

Fungal Infection Diagnosis Segment by Type

Galactomannan Test

(1 to 3)-β-D-glucan Experiment

Fungal Infection Diagnosis Segment by Application

Hospital

Laboratory

Others

Fungal Infection Diagnosis Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Fungal Infection Diagnosis status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Fungal Infection Diagnosis key companies, revenue, market share, and recent developments.

3. To split the Fungal Infection Diagnosis breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Fungal Infection Diagnosis market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Fungal Infection Diagnosis significant trends, drivers, influence factors in global and regions.

6. To analyze Fungal Infection Diagnosis competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Fungal Infection Diagnosis market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Fungal Infection Diagnosis and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Fungal Infection Diagnosis.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Fungal Infection Diagnosis industry.

Chapter 3: Detailed analysis of Fungal Infection Diagnosis company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Fungal Infection Diagnosis in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Fungal Infection Diagnosis in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Fungal Infection Diagnosis Industry Trends Table 2. Fungal Infection Diagnosis Industry Drivers Table 3. Fungal Infection Diagnosis Industry Opportunities and Challenges Table 4. Fungal Infection Diagnosis Industry Restraints Table 5. Global Fungal Infection Diagnosis Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Fungal Infection Diagnosis Revenue Share by Company (2021-2026) Table 7. Global Fungal Infection Diagnosis Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Fungal Infection Diagnosis Key Company Manufacturing Base & Headquarters Table 9. Global Fungal Infection Diagnosis Company, Product Type & Application Table 10. Global Fungal Infection Diagnosis Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Fungal Infection Diagnosis by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Galactomannan Test Table 15. Significant Companies of (1 to 3)-β-D-glucan Experiment Table 16. Global Fungal Infection Diagnosis Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Fungal Infection Diagnosis Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Fungal Infection Diagnosis Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Fungal Infection Diagnosis Sales Value Share by Type (2021-2026) Table 20. Global Fungal Infection Diagnosis Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Hospital Table 22. Significant Companies of Laboratory Table 23. Significant Companies of Others Table 24. Global Fungal Infection Diagnosis Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Fungal Infection Diagnosis Sales Value by Application (2021-2026) & (US$ Million) Table 26. Global Fungal Infection Diagnosis Sales Value by Application (2027-2032) & (US$ Million) Table 27. Global Fungal Infection Diagnosis Sales Value Share by Application (2021-2026) Table 28. Global Fungal Infection Diagnosis Sales Value Share by Application (2027-2032) Table 29. Global Fungal Infection Diagnosis Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Fungal Infection Diagnosis Sales Value by Region (2021-2026) & (US$ Million) Table 31. Global Fungal Infection Diagnosis Sales Value Share by Region (2021-2026) Table 32. Global Fungal Infection Diagnosis Sales Value by Region (2027-2032) & (US$ Million) Table 33. Global Fungal Infection Diagnosis Sales Value Share by Region (2027-2032) Table 34. Global Fungal Infection Diagnosis Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Fungal Infection Diagnosis Sales Value by Country (2021-2026) & (US$ Million) Table 36. Global Fungal Infection Diagnosis Sales Value Market Share by Country (2021-2026) Table 37. Global Fungal Infection Diagnosis Sales Value by Country (2027-2032) & (US$ Million) Table 38. Global Fungal Infection Diagnosis Sales Value Market Share by Country (2027-2032) Table 39. ASSOCIATES OF CAPE COD Company Information Table 40. ASSOCIATES OF CAPE COD Business Overview Table 41. ASSOCIATES OF CAPE COD Fungal Infection Diagnosis Revenue (US$ Million) and Gross Margin (2021-2026) Table 42. ASSOCIATES OF CAPE COD Fungal Infection Diagnosis Product Portfolio Table 43. ASSOCIATES OF CAPE COD Recent Development Table 44. BioRad Company Information Table 45. BioRad Business Overview Table 46. BioRad Fungal Infection Diagnosis Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. BioRad Fungal Infection Diagnosis Product Portfolio Table 48. BioRad Recent Development Table 49. IMMY Company Information Table 50. IMMY Business Overview Table 51. IMMY Fungal Infection Diagnosis Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. IMMY Fungal Infection Diagnosis Product Portfolio Table 53. IMMY Recent Development Table 54. Beijing Jinshanchuan Company Information Table 55. Beijing Jinshanchuan Business Overview Table 56. Beijing Jinshanchuan Fungal Infection Diagnosis Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. Beijing Jinshanchuan Fungal Infection Diagnosis Product Portfolio Table 58. Beijing Jinshanchuan Recent Development Table 59. Danna Biological Company Information Table 60. Danna Biological Business Overview Table 61. Danna Biological Fungal Infection Diagnosis Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. Danna Biological Fungal Infection Diagnosis Product Portfolio Table 63. Danna Biological Recent Development Table 64. Zhanjiang A & C Biological Ltd. Company Information Table 65. Zhanjiang A & C Biological Ltd. Business Overview Table 66. Zhanjiang A & C Biological Ltd. Fungal Infection Diagnosis Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Zhanjiang A & C Biological Ltd. Fungal Infection Diagnosis Product Portfolio Table 68. Zhanjiang A & C Biological Ltd. Recent Development Table 69. Research Programs/Design for This Report Table 70. Authors List of This Report Table 71. Secondary Sources Table 72. Primary Sources List of Figures Figure 1. Fungal Infection Diagnosis Product Image Figure 2. Global Fungal Infection Diagnosis Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Fungal Infection Diagnosis Market Size (2021-2032) & (US$ Million) Figure 4. Global Fungal Infection Diagnosis Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Galactomannan Test Image Figure 8. (1 to 3)-β-D-glucan Experiment Image Figure 9. Global Fungal Infection Diagnosis Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Fungal Infection Diagnosis Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Fungal Infection Diagnosis Sales Value Share by Type (2021-2032) Figure 12. Hospital Image Figure 13. Laboratory Image Figure 14. Others Image Figure 15. Global Fungal Infection Diagnosis Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Fungal Infection Diagnosis Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Fungal Infection Diagnosis Sales Value Share by Application (2021-2032) Figure 18. Global Fungal Infection Diagnosis Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Fungal Infection Diagnosis Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 20. North America Fungal Infection Diagnosis Sales Value (2021-2032) & (US$ Million) Figure 21. North America Fungal Infection Diagnosis Sales Value Share by Country (%), 2025 VS 2032 Figure 22. Europe Fungal Infection Diagnosis Sales Value (2021-2032) & (US$ Million) Figure 23. Europe Fungal Infection Diagnosis Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Asia-Pacific Fungal Infection Diagnosis Sales Value (2021-2032) & (US$ Million) Figure 25. Asia-Pacific Fungal Infection Diagnosis Sales Value Share by Country (%), 2025 VS 2032 Figure 26. South America Fungal Infection Diagnosis Sales Value (2021-2032) & (US$ Million) Figure 27. South America Fungal Infection Diagnosis Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Middle East & Africa Fungal Infection Diagnosis Sales Value (2021-2032) & (US$ Million) Figure 29. Middle East & Africa Fungal Infection Diagnosis Sales Value Share by Country (%), 2025 VS 2032 Figure 30. USA Fungal Infection Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 31. USA Fungal Infection Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 32. USA Fungal Infection Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 33. Canada Fungal Infection Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. Canada Fungal Infection Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. Canada Fungal Infection Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Mexico Fungal Infection Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Mexico Fungal Infection Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Mexico Fungal Infection Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Germany Fungal Infection Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Germany Fungal Infection Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Germany Fungal Infection Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. France Fungal Infection Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. France Fungal Infection Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. France Fungal Infection Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. U.K. Fungal Infection Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. U.K. Fungal Infection Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. U.K. Fungal Infection Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Italy Fungal Infection Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Italy Fungal Infection Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Italy Fungal Infection Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Spain Fungal Infection Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Spain Fungal Infection Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Spain Fungal Infection Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Russia Fungal Infection Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Russia Fungal Infection Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Russia Fungal Infection Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Netherlands Fungal Infection Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Netherlands Fungal Infection Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Netherlands Fungal Infection Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Nordic Countries Fungal Infection Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Nordic Countries Fungal Infection Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Nordic Countries Fungal Infection Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. China Fungal Infection Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. China Fungal Infection Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. China Fungal Infection Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Japan Fungal Infection Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Japan Fungal Infection Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Japan Fungal Infection Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. South Korea Fungal Infection Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. South Korea Fungal Infection Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. South Korea Fungal Infection Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. India Fungal Infection Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. India Fungal Infection Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. India Fungal Infection Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Australia Fungal Infection Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Australia Fungal Infection Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Australia Fungal Infection Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Southeast Asia Fungal Infection Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Southeast Asia Fungal Infection Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Southeast Asia Fungal Infection Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Brazil Fungal Infection Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Brazil Fungal Infection Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Brazil Fungal Infection Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Argentina Fungal Infection Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Argentina Fungal Infection Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Argentina Fungal Infection Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Chile Fungal Infection Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Chile Fungal Infection Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Chile Fungal Infection Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Colombia Fungal Infection Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Colombia Fungal Infection Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Colombia Fungal Infection Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Peru Fungal Infection Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Peru Fungal Infection Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Peru Fungal Infection Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Saudi Arabia Fungal Infection Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Saudi Arabia Fungal Infection Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Fungal Infection Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Israel Fungal Infection Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Israel Fungal Infection Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Israel Fungal Infection Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. UAE Fungal Infection Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. UAE Fungal Infection Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. UAE Fungal Infection Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Turkey Fungal Infection Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Turkey Fungal Infection Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Turkey Fungal Infection Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Iran Fungal Infection Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Iran Fungal Infection Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Iran Fungal Infection Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Egypt Fungal Infection Diagnosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Egypt Fungal Infection Diagnosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Egypt Fungal Infection Diagnosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Years Considered Figure 115. Research Process Figure 116. Key Executives Interviewed

Scope & coverage.

Types
  • Galactomannan Test
  • (1 to 3)-β-D-glucan Experiment
Applications
  • Hospital
  • Laboratory
  • Others
Companies covered
  • ASSOCIATES OF CAPE COD
  • BioRad
  • IMMY
  • Beijing Jinshanchuan
  • Danna Biological
  • Zhanjiang A & C Biological Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Fungal Infection Diagnosis Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Fungal Infection Diagnosis Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Fungal Infection Diagnosis Market Dynamics
  1. 2.1 Fungal Infection Diagnosis Industry Trends
  2. 2.2 Fungal Infection Diagnosis Industry Drivers
  3. 2.3 Fungal Infection Diagnosis Industry Opportunities and Challenges
  4. 2.4 Fungal Infection Diagnosis Industry Restraints
3 Fungal Infection Diagnosis Market by Company
  1. 3.1 Global Fungal Infection Diagnosis Company Revenue Ranking in 2025
  2. 3.2 Global Fungal Infection Diagnosis Revenue by Company (2021-2026)
  3. 3.3 Global Fungal Infection Diagnosis Company Ranking (2024-2026)
  4. 3.4 Global Fungal Infection Diagnosis Company Manufacturing Base and Headquarters
  5. 3.5 Global Fungal Infection Diagnosis Company Product Type and Application
  6. 3.6 Global Fungal Infection Diagnosis Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Fungal Infection Diagnosis Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Fungal Infection Diagnosis Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Fungal Infection Diagnosis Market by Type
  1. 4.1 Fungal Infection Diagnosis Type Introduction
  2. 4.1.1 Galactomannan Test
  3. 4.1.2 (1 to 3)-β-D-glucan Experiment
  4. 4.2 Global Fungal Infection Diagnosis Sales Value by Type
  5. 4.2.1 Global Fungal Infection Diagnosis Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Fungal Infection Diagnosis Sales Value by Type (2021-2032)
  7. 4.2.3 Global Fungal Infection Diagnosis Sales Value Share by Type (2021-2032)
5 Fungal Infection Diagnosis Market by Application
  1. 5.1 Fungal Infection Diagnosis Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Laboratory
  4. 5.1.3 Others
  5. 5.2 Global Fungal Infection Diagnosis Sales Value by Application
  6. 5.2.1 Global Fungal Infection Diagnosis Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Fungal Infection Diagnosis Sales Value by Application (2021-2032)
  8. 5.2.3 Global Fungal Infection Diagnosis Sales Value Share by Application (2021-2032)
6 Fungal Infection Diagnosis Regional Value Analysis
  1. 6.1 Global Fungal Infection Diagnosis Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Fungal Infection Diagnosis Sales Value by Region (2021-2032)
  3. 6.2.1 Global Fungal Infection Diagnosis Sales Value by Region: 2021-2026
  4. 6.2.2 Global Fungal Infection Diagnosis Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Fungal Infection Diagnosis Sales Value (2021-2032)
  7. 6.3.2 North America Fungal Infection Diagnosis Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Fungal Infection Diagnosis Sales Value (2021-2032)
  10. 6.4.2 Europe Fungal Infection Diagnosis Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Fungal Infection Diagnosis Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Fungal Infection Diagnosis Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Fungal Infection Diagnosis Sales Value (2021-2032)
  16. 6.6.2 South America Fungal Infection Diagnosis Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Fungal Infection Diagnosis Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Fungal Infection Diagnosis Sales Value Share by Country, 2025 VS 2032
7 Fungal Infection Diagnosis Country-level Value Analysis
  1. 7.1 Global Fungal Infection Diagnosis Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Fungal Infection Diagnosis Sales Value by Country (2021-2032)
  3. 7.2.1 Global Fungal Infection Diagnosis Sales Value by Country (2021-2026)
  4. 7.2.2 Global Fungal Infection Diagnosis Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Fungal Infection Diagnosis Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Fungal Infection Diagnosis Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Fungal Infection Diagnosis Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Fungal Infection Diagnosis Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Fungal Infection Diagnosis Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Fungal Infection Diagnosis Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Fungal Infection Diagnosis Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Fungal Infection Diagnosis Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Fungal Infection Diagnosis Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Fungal Infection Diagnosis Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Fungal Infection Diagnosis Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Fungal Infection Diagnosis Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Fungal Infection Diagnosis Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Fungal Infection Diagnosis Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Fungal Infection Diagnosis Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Fungal Infection Diagnosis Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Fungal Infection Diagnosis Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Fungal Infection Diagnosis Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Fungal Infection Diagnosis Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Fungal Infection Diagnosis Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Fungal Infection Diagnosis Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Fungal Infection Diagnosis Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Fungal Infection Diagnosis Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Fungal Infection Diagnosis Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Fungal Infection Diagnosis Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Fungal Infection Diagnosis Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Fungal Infection Diagnosis Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Fungal Infection Diagnosis Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Fungal Infection Diagnosis Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Fungal Infection Diagnosis Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Fungal Infection Diagnosis Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Fungal Infection Diagnosis Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Fungal Infection Diagnosis Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Fungal Infection Diagnosis Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Fungal Infection Diagnosis Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Fungal Infection Diagnosis Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Fungal Infection Diagnosis Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Fungal Infection Diagnosis Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Fungal Infection Diagnosis Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Fungal Infection Diagnosis Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Fungal Infection Diagnosis Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Fungal Infection Diagnosis Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Fungal Infection Diagnosis Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Fungal Infection Diagnosis Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Fungal Infection Diagnosis Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Fungal Infection Diagnosis Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Fungal Infection Diagnosis Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Fungal Infection Diagnosis Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Fungal Infection Diagnosis Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Fungal Infection Diagnosis Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Fungal Infection Diagnosis Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Fungal Infection Diagnosis Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Fungal Infection Diagnosis Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Fungal Infection Diagnosis Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Fungal Infection Diagnosis Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Fungal Infection Diagnosis Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Fungal Infection Diagnosis Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Fungal Infection Diagnosis Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Fungal Infection Diagnosis Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Fungal Infection Diagnosis Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Fungal Infection Diagnosis Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Fungal Infection Diagnosis Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Fungal Infection Diagnosis Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Fungal Infection Diagnosis Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Fungal Infection Diagnosis Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Fungal Infection Diagnosis Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Fungal Infection Diagnosis Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Fungal Infection Diagnosis Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Fungal Infection Diagnosis Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Fungal Infection Diagnosis Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Fungal Infection Diagnosis Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Fungal Infection Diagnosis Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Fungal Infection Diagnosis Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Fungal Infection Diagnosis Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Fungal Infection Diagnosis Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Fungal Infection Diagnosis Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Fungal Infection Diagnosis Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Fungal Infection Diagnosis Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Fungal Infection Diagnosis Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Fungal Infection Diagnosis Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Fungal Infection Diagnosis Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Fungal Infection Diagnosis Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Fungal Infection Diagnosis Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Fungal Infection Diagnosis Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 ASSOCIATES OF CAPE COD
  2. 8.1.1 ASSOCIATES OF CAPE COD Company Information
  3. 8.1.2 ASSOCIATES OF CAPE COD Business Overview
  4. 8.1.3 ASSOCIATES OF CAPE COD Fungal Infection Diagnosis Revenue and Gross Margin (2021-2026)
  5. 8.1.4 ASSOCIATES OF CAPE COD Fungal Infection Diagnosis Product Portfolio
  6. 8.1.5 ASSOCIATES OF CAPE COD Recent Developments
  7. 8.2 BioRad
  8. 8.2.1 BioRad Company Information
  9. 8.2.2 BioRad Business Overview
  10. 8.2.3 BioRad Fungal Infection Diagnosis Revenue and Gross Margin (2021-2026)
  11. 8.2.4 BioRad Fungal Infection Diagnosis Product Portfolio
  12. 8.2.5 BioRad Recent Developments
  13. 8.3 IMMY
  14. 8.3.1 IMMY Company Information
  15. 8.3.2 IMMY Business Overview
  16. 8.3.3 IMMY Fungal Infection Diagnosis Revenue and Gross Margin (2021-2026)
  17. 8.3.4 IMMY Fungal Infection Diagnosis Product Portfolio
  18. 8.3.5 IMMY Recent Developments
  19. 8.4 Beijing Jinshanchuan
  20. 8.4.1 Beijing Jinshanchuan Company Information
  21. 8.4.2 Beijing Jinshanchuan Business Overview
  22. 8.4.3 Beijing Jinshanchuan Fungal Infection Diagnosis Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Beijing Jinshanchuan Fungal Infection Diagnosis Product Portfolio
  24. 8.4.5 Beijing Jinshanchuan Recent Developments
  25. 8.5 Danna Biological
  26. 8.5.1 Danna Biological Company Information
  27. 8.5.2 Danna Biological Business Overview
  28. 8.5.3 Danna Biological Fungal Infection Diagnosis Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Danna Biological Fungal Infection Diagnosis Product Portfolio
  30. 8.5.5 Danna Biological Recent Developments
  31. 8.6 Zhanjiang A & C Biological Ltd.
  32. 8.6.1 Zhanjiang A & C Biological Ltd. Company Information
  33. 8.6.2 Zhanjiang A & C Biological Ltd. Business Overview
  34. 8.6.3 Zhanjiang A & C Biological Ltd. Fungal Infection Diagnosis Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Zhanjiang A & C Biological Ltd. Fungal Infection Diagnosis Product Portfolio
  36. 8.6.5 Zhanjiang A & C Biological Ltd. Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst